Imbio

Imbio is a medical imaging software company that provides AI-powered analysis for lung and cardiothoracic conditions. The company's technology uses artificial intelligence and machine learning to analyze medical images, such as CT scans, to provide quantitative and personalized data for physicians.

Imbio's software is designed to integrate into existing clinical workflows, automatically receiving image series and returning detailed analyses and 3D visualizations without requiring additional work from medical staff. This service aids in the diagnosis and treatment of both acute and chronic diseases by transforming standard medical images into detailed maps that highlight and quantify disease-specific anomalies.

The primary market for Imbio is the healthcare industry, with its client base consisting of physicians and health systems. The company operates on a B2B model, providing its software solutions to these healthcare providers. In December 2023, Imbio was acquired by 4DMedical, a company specializing in lung function imaging software, to create a more comprehensive portfolio of cardiothoracic imaging analysis tools.

Keywords: medical imaging, AI, machine learning, cardiothoracic, lung analysis, quantitative analysis, 3D visualization, healthcare, diagnostics, CT scans